GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Amneal Pharmaceuticals
Amneal Pharmaceuticals is a major manufacturer of generic and specialty pharmaceuticals. Its stock price reflects pricing pressure in the generics market and the company's ability to introduce more complex and profitable products.
Share prices of companies in the market segment - Pharma other
Amneal is a major manufacturer of generic and specialty pharmaceuticals. We classify it as part of the other pharmaceuticals sector, and the chart below illustrates the overall dynamics of this market, characterized by pricing pressure and competition.
Broad Market Index - GURU.Markets
Amneal Pharmaceuticals is a major manufacturer of generic and specialty pharmaceuticals. Its scale makes it a significant component of the GURU.Markets index. The chart below reflects the dynamics of the entire market. Find out how this pharmaceutical manufacturer compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
AMRX - Daily change in the company's share price Amneal Pharmaceuticals
Price fluctuations for Amneal Pharmaceuticals, a manufacturer of generic and specialty drugs, reflect the dynamics of the pharmaceutical market. Change_co demonstrates sensitivity to price competition and new product approvals. This metric is an important element of the formulas on System.GURU.Markets, which analyzes the affordable drug sector.
Daily change in the price of a set of shares in a market segment - Pharma other
Amneal Pharmaceuticals, Inc. is a major manufacturer of generic and specialty drugs. This chart shows the average daily volatility of the pharmaceutical sector. Comparison with AMRX helps assess its sensitivity to price competition and regulatory approvals.
Daily change in the price of a broad market stock, index - GURU.Markets
Amneal Pharmaceuticals is a major manufacturer of generic and specialty pharmaceuticals. The pharmaceutical sector may operate by its own rules, but stocks of such companies are still subject to overall market trends. The chart below provides context for assessing Amneal's performance.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Amneal Pharmaceuticals
Amneal is one of the largest producers of generic and specialty pharmaceuticals. Its annual growth reflects a complex process of acquisition integration and its strategy of focusing on the most profitable segments.
Annual dynamics of market capitalization of the market segment - Pharma other
Amneal Pharmaceuticals, Inc. is a major manufacturer of generic and specialty pharmaceuticals. The company operates in a highly competitive market with constant pricing pressure. The chart below shows how its diversified portfolio and focus on developing complex drugs impact its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Amneal, a manufacturer of generic and specialty drugs, operates in the defensive healthcare sector. However, its stock price reflects not only stable demand but also the intense competition and pricing pressure in the generics market. The chart tells the story of the struggle for profitability in the challenging pharmaceutical sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Amneal Pharmaceuticals
Amneal, one of the largest generic drug manufacturers in the US. The monthly fluctuations on the chart reflect price competition in the generics market, the success of new generic drug launches, and the growth of its business in producing more complex, specialized drugs.
Monthly dynamics of market capitalization of the market segment - Pharma other
Amneal Pharmaceuticals is a generic and specialty pharmaceutical company. Its sector dynamics, shown in the chart, reflect pricing pressure on generics and brand-name patents. Against this backdrop, one can appreciate how Amneal's diversified portfolio and focus on complex products help it compete in this challenging market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Amneal Pharmaceuticals is a major manufacturer of generic and specialty pharmaceuticals. The generic market is highly competitive and dependent on patent expirations. The chart below shows how defensive demand for medications has allowed Amneal shares to be less volatile than the market, but also to underperform during periods of rapid growth.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Amneal Pharmaceuticals
The weekly performance of Amneal Pharmaceuticals, a manufacturer of generic and specialty drugs, reflects pharmaceutical market news. Shares react to new drug approvals, patent litigation, and price competition. The chart below shows how short-term industry events impact the company's valuation.
Weekly dynamics of market capitalization of the market segment - Pharma other
How are Amneal, a generic drug maker, performing relative to the broader pharmaceutical sector? This chart compares the company's weekly performance with the industry average. This helps us understand whether the company is reacting more strongly to news about price competition and patent disputes than innovative drug developers, or whether it's simply following general trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Amneal Pharmaceuticals is a major manufacturer of generic and specialty drugs. This chart compares its weekly performance to the broader market. It helps understand whether its diversified product portfolio allows it to be less volatile than the market, or whether pricing pressure in the generics sector is creating its own risks.
Market capitalization of the company, segment and market as a whole
AMRX - Market capitalization of the company Amneal Pharmaceuticals
Amneal Pharmaceuticals' market capitalization reflects its position in the competitive generic and specialty pharmaceuticals market. Investors' valuation of the company depends on its ability to introduce new generic drugs and develop its own brand portfolio. The chart illustrates the challenges and opportunities of this complex business.
AMRX - Share of the company's market capitalization Amneal Pharmaceuticals within the market segment - Pharma other
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. Its share of the pharmaceutical sector's market capitalization reflects the scale of its production capacity and diversified product portfolio. The chart shows how investors assess its ability to compete in the generics market and develop new drugs.
Market capitalization of the market segment - Pharma other
Here's a chart showing the combined market capitalization of generic and complex pharmaceutical manufacturers. Amneal Pharmaceuticals is one of the largest and most diversified players. The graph demonstrates the scale of the industry that makes medicines more accessible to millions of patients.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows the market value of one of the largest producers of generic drugs—affordable alternatives to expensive medications. Amneal Pharmaceuticals' market capitalization reflects the healthcare system's need to reduce costs. Its share of the economy represents the weight of an industry that makes treatment more accessible to millions of people.
Book value capitalization of the company, segment and market as a whole
AMRX - Book value capitalization of the company Amneal Pharmaceuticals
This chart illustrates the physical assets of Amneal Pharmaceuticals, a major manufacturer of generic and specialty drugs. The line represents the combined value of its factories, laboratories, and approved drug portfolio. The dynamics show how the company is investing in expanding production capacity and developing new drugs.
AMRX - Share of the company's book capitalization Amneal Pharmaceuticals within the market segment - Pharma other
Amneal Pharmaceuticals' resource base is an extensive network of factories producing generic and specialty drugs. The chart shows the company's significant share of pharmaceutical production capacity, reflecting its scale as a key drugmaker.
Market segment balance sheet capitalization - Pharma other
Amneal Pharmaceuticals is a major manufacturer of generic and specialty drugs. Unlike "light" biotechs, the company owns an extensive network of factories, making it very capital-intensive. Is such production capacity the norm for the pharmaceutical industry? The chart below shows the total material weight of the entire sector.
Book value of all companies included in the broad market index - GURU.Markets
Amneal Pharmaceuticals' assets include large generic and specialty drug manufacturing plants, as well as a portfolio of approved medications. Its book value reflects its production capacity and ability to make medications more affordable. The chart shows its physical scale within the pharmaceutical industry.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Amneal Pharmaceuticals
Amneal Pharmaceuticals produces generic and specialty drugs. Its balance sheet includes its manufacturing facilities and inventory. Its market valuation depends on its ability to launch new generic drugs and the success of its more complex branded products. The chart shows how the market values its manufacturing portfolio and R&D pipeline.
Market to book capitalization ratio in a market segment - Pharma other
Amneal Pharmaceuticals is a major manufacturer of generic and specialty drugs. The company has significant production capacity. The chart shows how the market assesses its ability to generate profit from these assets in the highly competitive generics market.
Market to book capitalization ratio for the market as a whole
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. This chart shows how the market values the company, which operates in a highly competitive environment. Its valuation is a balance between the cost of its production capacity and the expected profitability from introducing new generic and branded drugs to market.
Debts of the company, segment and market as a whole
AMRX - Company debts Amneal Pharmaceuticals
Amneal Pharmaceuticals produces and markets a wide range of generic and specialty pharmaceuticals. The company's debt load often reflects its growth strategy through acquisitions and production capacity expansion. This chart illustrates how Amneal uses debt to strengthen its position in a competitive market.
Market segment debts - Pharma other
Amneal Pharmaceuticals develops and manufactures a wide range of generic and specialty pharmaceuticals. The generics industry is highly competitive, and profitability depends on the scale of production and speed of product introduction. This chart shows the typical debt load for pharmaceutical companies, allowing one to evaluate Amneal's financial strategy for portfolio expansion.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Amneal Pharmaceuticals
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The generics market is highly competitive and characterized by pricing pressure. This chart shows the company's debt load, which is an important factor in its ability to invest in new drug development and withstand competition.
Market segment debt to market segment book capitalization - Pharma other
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The business requires investment in research and development and production, and frequently grows through acquisitions. This chart compares the company's debt to the total market capitalization of the pharmaceutical sector, highlighting its financial strategy in a competitive environment.
Debt to book value of all companies in the market
Amneal Pharmaceuticals, as a major generic drug manufacturer, plays a vital role in the healthcare system. This chart compares the company's debt to the overall book value of the economy. It helps assess the financial weight of this pharmaceutical giant and how it manages debt to support its large-scale production.
P/E of the company, segment and market as a whole
P/E - Amneal Pharmaceuticals
This chart shows the valuation of Amneal Pharmaceuticals, a manufacturer of generic and specialty drugs. In the competitive pharmaceutical industry, this metric reflects how investors view its product portfolio and ability to bring new drugs to market. It helps determine whether the market sees growth potential or is wary of pricing pressure.
P/E of the market segment - Pharma other
This chart shows the average valuation for the pharmaceutical sector, specifically generic drug manufacturers, where Amneal operates. This metric reflects overall investor sentiment toward the price-competitive industry and helps understand how Amneal compares to other generic drug makers.
P/E of the market as a whole
Amneal Pharmaceuticals is a manufacturer of a wide range of generic and specialty branded medications. The company strives to make medicines more accessible, playing a vital role in the healthcare system. This chart, showing general market trends, provides insight into investor sentiment toward the pharmaceutical sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Amneal Pharmaceuticals
Amneal Pharmaceuticals produces a wide range of generic and specialty pharmaceuticals. This chart reflects market expectations for future profits, which depend on the successful launch of new generics and growth in branded product sales. It assesses the company's competitiveness and production potential.
%20P%2FE%20Amneal%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Amneal-Pharmaceuticals&v=1772641279986 "Chart of the company's future (projected) P/E Amneal Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma other
Amneal Pharmaceuticals is a pharmaceutical company specializing in the development, production, and sale of generic, brand-name, and biosimilar drugs. The company's portfolio covers a wide range of therapeutic areas. This chart reflects average expectations for the pharmaceutical industry, allowing one to assess Amneal's position relative to its competitors.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772641279989 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Amneal Pharmaceuticals is a manufacturer of generic drugs and specialty pharmaceuticals. The generics business depends on patent expirations on original drugs and price competition. This makes it less dependent on general economic cycles but sensitive to the regulatory environment.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772641280006 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Amneal Pharmaceuticals
Amneal Pharmaceuticals is a company specializing in the development and production of generic and specialty pharmaceuticals. Its profitability depends on the successful launch of new generic drugs and competition in this sector. This chart shows how patent expirations on popular drugs and operational efficiency impact financial results.
Profit of companies in the market segment - Pharma other
Amneal Pharmaceuticals is a manufacturer of generics (analogs of branded drugs) and specialty pharmaceuticals. This chart shows the overall profitability of the pharmaceutical sector. Amneal's profitability depends on the successful launch of new generics after patent expiration and competition. Its results reflect pricing pressure and the dynamics of affordable medicine.
Overall market profit
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. Demand for generics often remains stable or even increases during economic downturns, when consumers and healthcare systems seek cost savings. Therefore, Amneal's business may exhibit dynamics opposite to those shown in this overall profitability chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Amneal Pharmaceuticals
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The future profit forecasts presented in this chart depend on the successful launch of new generic drugs, competition, and pricing pressure in the industry. It allows investors to assess analysts' views on the company's product portfolio and its operating performance.
%20profit%20of%20the%20company%20Amneal%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Amneal-Pharmaceuticals&v=1772641280061 "Graph of future (projected) profit of the company Amneal Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma other
Amneal Pharmaceuticals produces a wide range of generic and specialty pharmaceuticals. This chart shows profitability forecasts for the pharmaceutical industry. It reflects expectations related to patent expirations on original drugs and price competition in the generic market, which is key to Amneal's business model.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772641280093 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The generic market helps contain healthcare costs. The overall market profit forecast shown here reflects the state of the economy. During periods of growth and recession, demand for more affordable medications remains high, providing Amneal with stable cash flow and the ability to invest in new developments.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772641280110 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Amneal Pharmaceuticals
Amneal Pharmaceuticals is a manufacturer of generic and specialty drugs. The generic market is highly competitive. The P/S ratio helps assess the scale of a business and its market share, showing how investors value each dollar of sales in the face of pricing pressure. It is an indicator of a company's effectiveness in competing for contracts and volume.
P/S market segment - Pharma other
Amneal Pharmaceuticals produces a wide range of generic and specialty pharmaceuticals. Their business model is based on offering more affordable alternatives to branded medications. This chart helps assess how the market perceives their product portfolio and their competitive position compared to other generic drug manufacturers.
P/S of the market as a whole
Amneal Pharmaceuticals produces and sells both generic and branded medications. The company's revenue depends on price competition in the generic market and the success of new products. This chart shows the average revenue estimate, allowing for a comparison of how the market values the hybrid business model in the pharmaceutical industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Amneal Pharmaceuticals
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. Its success depends on the launch of new generic drugs and the development of its branded portfolio. This chart shows how the market estimates the company's future revenue, given its pipeline of new generics and the potential of its specialty products.
%20P%2FS%20Amneal%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Amneal-Pharmaceuticals&v=1772641280171 "The graph of the company's future (projected) P/S Amneal Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma other
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The company's success depends on the timely launch of generic versions of its drugs and the development of its own brands. This chart compares Amneal's future sales expectations with those of other pharmaceutical companies, demonstrating how the market views its product portfolio and pipeline.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772641280194 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The company's focus on affordable medicines makes its business resilient. This chart shows overall market revenue expectations, and Amneal illustrates how the healthcare sector, by providing basic needs, forms a stable foundation for overall economic growth.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772641280250 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Amneal Pharmaceuticals
Amneal Pharmaceuticals is a pharmaceutical company specializing in the development, production, and sale of generics (analogs of brand-name drugs) and specialty medications. This chart shows revenue from sales of a broad portfolio of medications. Growth depends on the launch of new generics and successful competition in the pharmaceutical market.
Sales of companies in the market segment - Pharma other
Amneal Pharmaceuticals produces both generic and specialty branded medications. This chart clearly breaks down the company's revenue into these two segments. Investors can assess the balance between the highly competitive generic market and the higher-margin branded pharmaceuticals.
Overall market sales
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. Demand for generics often remains stable or even increases during economic downturns, as healthcare systems and patients seek cheaper alternatives. Therefore, the dynamics shown in this chart may be inversely correlated with Amneal's business.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Amneal Pharmaceuticals
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The company's revenue forecast depends on the successful launch of new generic drugs and market competition. This chart reflects analysts' expectations for sales volumes for both existing and new products in the company's portfolio.
%20sales%20of%20the%20company%20Amneal%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Amneal-Pharmaceuticals&v=1772641280396 "Schedule of future (projected) sales of the company Amneal Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma other
Amneal Pharmaceuticals produces a wide range of generic and specialty pharmaceuticals. The dynamics on this chart reflect projected revenues for the entire pharmaceutical sector. This allows one to assess overall industry trends, including pricing pressure on generics and demand for new drugs, which directly impact Amneal's strategy and profitability.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772641280411 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Amneal Pharmaceuticals produces and sells both generic and brand-name pharmaceuticals. Demand for generics is growing as healthcare systems and consumers seek cost-saving options. This trend in overall economic expectations can influence healthcare pricing policies. Slower growth could encourage a switch to Amneal's more affordable medications.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772641280438 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Amneal Pharmaceuticals
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. This chart shows how successfully the company competes in a highly competitive market. Its ability to generate profit depends on the speed of introducing new generic drugs to market and the efficiency of large-scale manufacturing.
Market segment marginality - Pharma other
Amneal Pharmaceuticals produces both generic and specialty pharmaceuticals. This chart shows how effectively the company competes in these two markets. Its ability to maintain above-average profitability indicates efficient manufacturing, successful new product launches, and a balanced portfolio.
Market marginality as a whole
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The generics business is highly competitive and focused on volume and low costs. This overall profitability chart illustrates the pricing pressures in the economy, which in the pharmaceutical industry manifests itself in the constant struggle to reduce drug prices after patents expire.
Employees in the company, segment and market as a whole
Number of employees in the company Amneal Pharmaceuticals
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. The size of a company's workforce reflects the scale of its production capacity, R&D for generics, and commercial infrastructure. This chart shows how the company balances the production of affordable generics with the development of more complex products.
Share of the company's employees Amneal Pharmaceuticals within the market segment - Pharma other
Amneal Pharmaceuticals is a major manufacturer of generic and specialty pharmaceuticals. This chart demonstrates its production capacity and scale within the pharmaceutical industry. It shows the significant share of chemists, technologists, quality control specialists, and manufacturing personnel Amneal employs in its sector to produce affordable medicines.
Number of employees in the market segment - Pharma other
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. This chart shows overall employment in the pharmaceutical industry. The growth in employment reflects increased demand for both affordable generics and innovative drugs, creating opportunities for Amneal's diversified portfolio.
Number of employees in the market as a whole
Amneal Pharmaceuticals is a major manufacturer of generic and specialty pharmaceuticals. Stable demand for its medications ensures stable employment at its manufacturing sites. The company is a vital part of the healthcare system, providing affordable medications and serving as a reliable employer.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Amneal Pharmaceuticals (AMRX)
Amneal Pharmaceuticals is a major manufacturer of generic and specialty drugs. Their business requires both R&D and significant manufacturing capacity. This chart will reflect the balance between R&D costs and plant efficiency. The figure will be higher than that of a retailer but lower than that of a pure-play biotech startup.
%20of%20the%20company%20Amneal%20Pharmaceuticals%20(AMRX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Amneal-Pharmaceuticals-AMRX&v=1772641280540 "Chart of market capitalization per employee (in thousands of dollars) of the company Amneal Pharmaceuticals (AMRX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Amneal Pharmaceuticals is a large generics (copycat drug) manufacturer that also invests in developing its own, more complex drugs. It operates under a hybrid model. This chart shows the industry average. It helps assess how the market views Amneal: whether it's more of a low-margin manufacturer or an innovative pharmaceutical company.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772641280547 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Amneal Pharmaceuticals is a manufacturer of generic and specialty pharmaceuticals. Pharmaceutical production requires both scientific research and significant manufacturing capacity. This chart allows us to assess how the market balances the value of developers' intellectual capital with the efficiency of a large production staff.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772641280568 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Amneal Pharmaceuticals (AMRX)
Amneal Pharmaceuticals is a major manufacturer of generic drugs and also develops its own specialized products. The generics business is a battle for low costs and speed to market. This chart shows how effectively the company manages its production capacity and R&D to squeeze profits in this low-margin environment.
%20Chart%20Amneal%20Pharmaceuticals%20(AMRX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Amneal-Pharmaceuticals-AMRX&v=1772641280578 "Company Profit Per Employee (in thousands of dollars) Chart Amneal Pharmaceuticals (AMRX)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Amneal Pharmaceuticals is a hybrid company: it's a major generics manufacturer and is trying to grow in specialty pharma. This chart shows the benchmark for the generics sector. The benchmark here is moderate. This is not an R&D business, but a manufacturing business. Profit per employee depends on the efficiency of its factories.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772641280586 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Amneal Pharmaceuticals is a major manufacturer of generics (analogs of brand-name drugs) and biosimilars. Their business is all about scaling production and efficiency. This chart shows the market-average profit per employee. It helps understand how efficient the generics sector, which Amneal represents, is in generating profit per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772641280590 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Amneal Pharmaceuticals (AMRX)
Amneal Pharmaceuticals, a manufacturer of generic and specialty drugs, shows the efficiency of its manufacturing and commercial operations in this chart. Revenue per employee depends on production volumes, the successful launch of new generics, and the management of a complex product portfolio. Growth indicates operational optimization.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Amneal-Pharmaceuticals-AMRX&v=1772641280597 "Sales chart per company employee Amneal Pharmaceuticals (AMRX)")
Sales per employee in the market segment - Pharma other
Amneal Pharmaceuticals is a major manufacturer of generics (drug analogs) and specialty medications. In this business, production efficiency and speed to market are crucial. This chart shows the average revenue per employee in this segment. It helps assess how effectively Amneal competes with other pharmaceutical companies.
Sales per employee for the market as a whole
Amneal Pharmaceuticals is a manufacturer of generics (analogs) and specialized brand-name medications. In the generics business, production efficiency and speed to market are key. This chart demonstrates how successfully Amneal manages its factories, generating maximum revenue per employee in a highly competitive market.
Short shares by company, segment and market as a whole
Shares shorted by company Amneal Pharmaceuticals (AMRX)
Amneal Pharmaceuticals is a major manufacturer of generics (copies of drugs) and specialized branded medications. The generics market is known for price wars. This chart shows the bets that the company will succumb to the pressure. Bears expect further price cuts on generics and competition in the biosimilar segment to hit profitability.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Amneal-Pharmaceuticals-AMRX&v=1772641280616 "Short Shares Chart for the Company Amneal Pharmaceuticals (AMRX)")
Shares shorted by market segment - Pharma other
Amneal Pharmaceuticals is a major manufacturer of generics (drug analogs) and specialty medications. The generics business is characterized by low prices and intense competition. This chart highlights the pessimism in the pharmaceutical industry. The increase in short positions in the sector is often linked to expectations of government pricing pressure or distributor consolidation, which impacts the margins of all manufacturers.
Shares shorted by the overall market
Amneal Pharmaceuticals (AMRX) is a manufacturer of generics (drug analogs) and specialty pharmaceuticals. Their business is characterized by high volumes and low margins. This chart shows the overall market fear. Although generics are a defensive sector, the rise in fear is often linked to concerns about pricing pressure in the sector or debt issues, which many generic manufacturers, including Amneal, face.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Amneal Pharmaceuticals (AMRX)
Amneal Pharmaceuticals is a major manufacturer of generic and specialty drugs. The business is competitive and relies on the approval of new generics. This chart for AMRX above 70 may reflect a successful product launch. AMRX below 30 is often associated with pricing pressure on generics or regulatory issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Amneal-Pharmaceuticals-AMRX&v=1772641280641 "RSI 14 indicator chart for the company's stock Amneal Pharmaceuticals (AMRX)")
RSI 14 Market Segment - Pharma other
Amneal Pharmaceuticals is a pharmaceutical manufacturer specializing in both generics (generic drugs) and the development of its own branded products. This chart reflects the overall state of the generics sector. It helps understand whether the entire segment is oversold due to persistent pricing pressure and intense competition.
RSI 14 for the overall market
Amneal Pharmaceuticals (AMRX), a generic drug manufacturer, demonstrates that its business is "defensive." During times of panic and recession, healthcare systems and patients seek savings by switching from expensive brand-name drugs to AMRX's cheaper generics, which could even increase its market share.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AMRX (Amneal Pharmaceuticals)
Amneal Pharmaceuticals is a manufacturer of a wide range of generic and specialty branded medications. This chart shows the average analyst consensus. Their forecasts take into account price erosion in the generic market, but also the potential for the launch of new, more complex drugs (such as injectables) and biosimilars, which have higher margins.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AMRX-Amneal-Pharmaceuticals&v=1772641280690 "A chart showing analyst consensus forecasts for the expected stock price. AMRX (Amneal Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price AMRX (Amneal Pharmaceuticals)
Amneal Pharmaceuticals is a large drug manufacturer. Their core business is generics, which generate high volume but low margins. They are also developing a specialized division, launching their own branded drugs. This chart shows how analysts assess this balance. It reflects the gap between the target price and the current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AMRX-Amneal-Pharmaceuticals&v=1772641280719 "A chart showing the difference between the consensus forecast and the actual stock price. AMRX (Amneal Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Amneal is a major producer of generics, or copies of drugs whose patents have expired. It's a low-margin but high-volume business. This chart shows analysts' overall expectations for the pharmaceutical sector. It reflects whether experts believe pricing pressure in the generics sector will ease.
Analysts' consensus forecast for the overall market share price
Amneal Pharmaceuticals (AMRX) is a major generic drug manufacturer and developer of more complex medications, such as injectables and inhalers. Their mission is affordable healthcare. This chart shows the general sentiment of experts. It reflects analysts' confidence in the stability of the healthcare system and price pressure.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Amneal Pharmaceuticals
Amneal Pharmaceuticals is a major generics manufacturer (generic versions of drugs) that is also investing in the development of more complex specialty drugs and biosimilars. This chart is an assessment of their hybrid model. It likely weighs pricing pressure in their generics business against the potential of their R&D pipeline for more complex drugs.
AKIMA Market Segment Index - Pharma other
Amneal Pharma (AMRX) is a major generics manufacturer that (unlike Teva) focuses on complex generics (injectables, inhalers) and specialized branded drugs. This aggregate metric evaluates companies. The graph shows the average value for the segment. This benchmark: how does Amneal's hybrid (complex generics + branded) model differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
Amneal is a major manufacturer of generics (copies of drugs). The company also develops complex branded drugs. It is a protective (healthcare) but low-margin business. This chart, reflecting the market average, provides a macro backdrop. It helps assess how Amneal fits within the overall macroeconomic picture affecting the sector.
